A druggable copper-signalling pathway that drives inflammation DOI Creative Commons
Stéphanie Solier, Sebastian Müller, Tatiana Cañeque

et al.

Nature, Journal Year: 2023, Volume and Issue: 617(7960), P. 386 - 394

Published: April 26, 2023

Abstract Inflammation is a complex physiological process triggered in response to harmful stimuli 1 . It involves cells of the immune system capable clearing sources injury and damaged tissues. Excessive inflammation can occur as result infection hallmark several diseases 2–4 The molecular bases underlying inflammatory responses are not fully understood. Here we show that cell surface glycoprotein CD44, which marks acquisition distinct phenotypes context development, immunity cancer progression, mediates uptake metals including copper. We identify pool chemically reactive copper (ii) mitochondria macrophages catalyses NAD(H) redox cycling by activating hydrogen peroxide. Maintenance NAD + enables metabolic epigenetic programming towards state. Targeting mitochondrial with supformin (LCC-12), rationally designed dimer metformin, induces reduction pool, leading states oppose macrophage activation. LCC-12 interferes plasticity other settings reduces mouse models bacterial viral infections. Our work highlights central role regulator unveils therapeutic strategy based on reprogramming control states.

Language: Английский

Disulfidptosis: a new target for metabolic cancer therapy DOI Creative Commons

Peijie Zheng,

Chuntao Zhou,

Yuemin Ding

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2023, Volume and Issue: 42(1)

Published: April 27, 2023

Abstract Altered metabolism is a hallmark of cancer and presents vulnerability that can be exploited in treatment. Regulated cell death (RCD) plays crucial role metabolic therapy. A recent study has identified new metabolic-related RCD known as disulfidptosis. Preclinical findings suggest therapy using glucose transporter (GLUT) inhibitors trigger disulfidptosis inhibit growth. In this review, we summarize the specific mechanisms underlying outline potential future research directions. We also discuss challenges may arise clinical translation research.

Language: Английский

Citations

178

ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis DOI Creative Commons
Feng He, Peng Zhang, Junlai Liu

et al.

Journal of Hepatology, Journal Year: 2023, Volume and Issue: 79(2), P. 362 - 377

Published: March 28, 2023

Language: Английский

Citations

174

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma DOI Creative Commons
Genhao Zhang, Jianping Sun, Xianwei Zhang

et al.

Scientific Reports, Journal Year: 2022, Volume and Issue: 12(1)

Published: July 5, 2022

Abstract Increased intracellular toxicity due to an imbalance in copper homeostasis caused by ion accumulation could regulate the rate of cancer cell growth and proliferation. The goal this study was create a novel Cuproptosis-related lncRNA signature that may be utilized predict survival immunotherapy HCC patients. Cuproptosis-associated lncRNAs differentially expressed between tumor tissue normal were discovered first. By LASSO-Cox analysis, overlapping then build signature, which might used patient prognosis responsiveness immune checkpoint blockade (ICB) therapy. Differences infiltration subpopulations high low-risk score subgroups also analyzed. Moreover, nomogram based on clinical features developed demonstrated have good predictive potential. Finally, qRT-PCR performed HerpG2 MHCC-97H lines explore whether these indeed involved process Cuproptosis. In summary, we created prognostic profile linked Cuproptosis forecast response immunotherapy, provide new potential non-apoptotic therapeutic perspective for

Language: Английский

Citations

169

A Hollow Amorphous Bimetal Organic Framework for Synergistic Cuproptosis/Ferroptosis/Apoptosis Anticancer Therapy via Disrupting Intracellular Redox Homeostasis and Copper/Iron Metabolisms DOI
Weijun Xu, Junmin Qian,

Guanghui Hou

et al.

Advanced Functional Materials, Journal Year: 2022, Volume and Issue: 32(40)

Published: July 30, 2022

Abstract Cuproptosis is a very newly recognized regulated cell death modality that distinct from known mechanisms and shows enormous prospect in cancer treatment. However, its efficacy copper‐dependent restricted by strictly copper metabolism. Herein, novel copper/iron hybrid hollow amorphous metal organic framework (HaMOF) developed as an oxidative stress amplifier metabolic disrupter for synergistic cuproptosis/ferroptosis/apoptosis anticancer therapy. The HaMOF fabricated Cu 2+ , 3,3′‐dithiobis(propionohydrazide) Fe 3+ via unsaturated coordination‐etching integration strategy, then doxorubicin loaded followed surface decoration with hyaluronan. obtained DOX@Fe/CuTH exhibits tumor microenvironment‐triggered catalytic therapeutic property, wherein it can amplify cellular simultaneously boosting H 2 O production depleting glutathione. Moreover, cause mitochondrial dysfunction downregulate the expressions of transporter ATP7A iron FPN 1, thereby leading to disorders high retentions cytoplasm •OH generation. overloaded lipoylated protein dihydrolipoamide S‐acetyltransferase aggregation lead cuproptosis. Collectively, both augmented induce potent ferroptosis, which synergizes cuproptosis DOX‐mediated apoptosis efficiently suppress growth. This bimetallic nanoplatform provides new paradigm boost cuproptosis‐related therapies.

Language: Английский

Citations

166

A druggable copper-signalling pathway that drives inflammation DOI Creative Commons
Stéphanie Solier, Sebastian Müller, Tatiana Cañeque

et al.

Nature, Journal Year: 2023, Volume and Issue: 617(7960), P. 386 - 394

Published: April 26, 2023

Abstract Inflammation is a complex physiological process triggered in response to harmful stimuli 1 . It involves cells of the immune system capable clearing sources injury and damaged tissues. Excessive inflammation can occur as result infection hallmark several diseases 2–4 The molecular bases underlying inflammatory responses are not fully understood. Here we show that cell surface glycoprotein CD44, which marks acquisition distinct phenotypes context development, immunity cancer progression, mediates uptake metals including copper. We identify pool chemically reactive copper (ii) mitochondria macrophages catalyses NAD(H) redox cycling by activating hydrogen peroxide. Maintenance NAD + enables metabolic epigenetic programming towards state. Targeting mitochondrial with supformin (LCC-12), rationally designed dimer metformin, induces reduction pool, leading states oppose macrophage activation. LCC-12 interferes plasticity other settings reduces mouse models bacterial viral infections. Our work highlights central role regulator unveils therapeutic strategy based on reprogramming control states.

Language: Английский

Citations

163